CPT 0372T: Non-Contact Fluorescence Wound Imaging for Bacterial Detection

CPT code 0372T represents a non-contact, real-time fluorescence imaging procedure that detects bacterial presence, maps bacterial location, and estimates bacterial load in wounds. The code enables clinicians to visualize bacterial patterns that can inform wound assessment and care planning. Nationally, adoption of this technology affects outpatient wound centers, physician offices, and ambulatory care practices that manage chronic and acute wounds, and it intersects with infection control and wound-care quality measurement.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage trends, clinical use cases, and how 0372T relates to common wound care services such as debridement and office visits. The publication summarizes typical sites of service, relevant clinical indications for imaging in wound management, and links to related procedural codes used in wound treatment workflows.

This report provides benchmarks for utilization and authorization practices, highlights recent policy developments affecting imaging-based wound assessment, and outlines clinical context for integrating fluorescence imaging into standard wound care pathways. Data not available in the input are noted where applicable.

Billing Code Overview

CPT code 0372T describes non-contact real-time fluorescence wound imaging used to identify bacterial presence, location, and load in a wound. The service uses imaging technology to visualize fluorescence signals from bacteria to support clinical assessment of infection risk and wound management.

Service type: Diagnostic imaging for wound assessment
Typical site of service: Outpatient wound care clinics, physician office-based wound centers, and other ambulatory settings

Clinical Context

A 62-year-old patient with type 2 diabetes mellitus presents to a wound care clinic for evaluation of a chronic non-healing foot ulcer. The wound has purulent drainage and surrounding erythema. The clinician performs a focused history and physical, documents wound size, depth, and appearance, and obtains vital signs. To assist with targeted wound management and to evaluate bacterial burden and distribution before debridement or topical therapy, the clinician performs non-contact real-time fluorescence wound imaging (0372T). The imaging is completed in the outpatient wound care suite or ambulatory clinic room, captured using a handheld fluorescence device, and images are saved to the electronic medical record. Results indicating focal areas of elevated bacterial load guide wound bed preparation (for example, selective or non-selective debridement), sampling for culture when indicated, and selection of topical antimicrobials or dressings. The visit typically occurs in the outpatient clinic or wound center; documentation includes clinical indication (for example, E11.621, L97.909), time of imaging, findings, and how the imaging influenced wound management decisions. Billing is submitted for 0372T in addition to the evaluation/management or wound care procedure codes when supported by documentation and payer rules.

Coding Specifications

Modifier	Description	When to Use

Taxonomy Code	Specialty	Notes
`208D00000X`	General Practice	Often primary care or family medicine clinicians performing point-of-care wound assessment in outpatient settings
`2086S0120X`	Wound Care Specialist	Specialists frequently performing wound imaging as part of comprehensive wound assessment and management
`207Q00000X`	Family Medicine Physician	Family physicians providing longitudinal wound care and coordinating imaging with wound treatment plans

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.909`	Non-pressure chronic ulcer of unspecified part of unspecified lower leg	Common chronic lower-extremity ulcer evaluated with fluorescence imaging to assess bacterial burden and distribution
`L89.309`	Pressure ulcer of unspecified site, stage 3	Pressure ulcers with suspected high bacterial load can be assessed with imaging to guide debridement and topical therapy
`L08.9`	Local infection of the skin and subcutaneous tissue, unspecified	Local skin/soft tissue infection adjacent to a wound where imaging helps detect and localize bacterial hotspots
`T81.4XXA`	Infection following a procedure, initial encounter	Post-procedural wound infections where imaging can assist in identifying bacterial presence and directing management
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are high-risk for infection; fluorescence imaging supports targeted treatment planning and monitoring

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`97597`	Debridement, open wound, first 20 sq cm or less	Performed when imaging identifies devitalized tissue and bacterial burden to justify selective or surgical debridement; imaging can guide targeted debridement sites
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Used for deeper debridement into subcutaneous tissue when indicated after assessment including fluorescence findings
`97602`	Wound(s) care, non-selective debridement; without anesthesia (eg, wet-to-moist dressings, enzymatic)	Applied when wound care includes non-selective debridement methods following imaging that informs bacterial management
`99213`	Established patient office or other outpatient visit, level 3	Common E/M code for routine follow-up visits where `0372T` may be performed alongside an established patient visit; documentation must support the selected E/M level

OpenPayer

Summary & Overview